Натальсид®
Producer: Stada Arzneimittel ("STADA Artsnaymittel") Germany
Code of automatic telephone exchange: B02BC
Release form: Firm dosage forms. Suppositories.
General characteristics. Structure:
One suppository contains: alginate sodium – 250 mg and bases for suppositories – solid fat (vitepsol) – enough before receiving suppository weighing 2,25 g.
Pharmacological properties:
Active agent of drug – sodium alginate – the natural polysaccharide received from brown algas. Renders the expressed haemo static, antiinflammatory and reparative action.
Indications to use:
Chronic proctal cracks in epithelization stages, the chronic bleeding hemorrhoids, a proctosigmoiditis and the inflammatory phenomena in a rectum in the postoperative period.
Route of administration and doses:
Rektalno. Suppository is entered into a rectum after spontaneous bowel emptying or a cleansing enema. To adults and children 14 years are more senior apply on 1 suppository 2 times a day. Duration of a course of treatment makes 7-14 days.
Side effects:
Allergic reactions are possible.
Contraindications:
Hypersensitivity to drug components. Children's age up to 14 years.
Note: Children from 6 months to 14 years are recommended to use a children's form – the drug Alginatol®. Натальсид® and Alginatol® differ only in the mass of suppositories. The mass of 1 Natalsida® suppository makes 2,25 g, and Alginatola® – 1,28 g.
Storage conditions:
In the place, unavailable to children, at a temperature not above 25 °C.
Issue conditions:
Without recipe
Packaging:
Натальсид® suppositories rectal 250 mg. On 5 suppositories in a blister strip packaging, 2 blister strip packagings together with the instruction on a medical use of drug place in a cardboard pack.